Search Results - Coretta Thomas Robinson

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas

    NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibrom... by Brian Weiss, Pamela L. Wolters, Scott R. Plotkin, Brigitte C. Widemann, James H. Tonsgard, Jaishri O. Blakeley, Jeffrey C. Allen, Elizabeth K. Schorry, Bruce R. Korf, Nathan Robison, Stewart Goldman, Alexander A. Vinks, Chie Emoto, Tsuyoshi Fukuda, Coretta Thomas Robinson, Gary Cutter, Lloyd J. Edwards, Eva Dombi, Nancy Ratner, Roger J. Packer, Michael J. Fisher

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial by Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: